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OBJECTIVES We sought to determine the long-term outcomes and risk factors for mortality in patients
with double-inlet left ventricle (DILV) or tricuspid atresia with transposed great arteries
(TA-TGA).
BACKGROUND Patients with DILV or TA-TGA are at risk of systemic outflow obstruction and a poor
outcome. The impact of various management strategies on the long-term outcomes of these
patients remains unknown.
METHODS We reviewed the outcomes of 164 consecutive pediatric patients with DILV or TA-TGA
who underwent surgical palliation between 1983 and 2002. Patients with a Holmes heart or
heterotaxy syndrome or who were lost to follow-up (n  24) were excluded. Risk factors for
mortality or the need for orthotopic heart transplantation (OHT) were assessed by
multivariate analysis.
RESULTS There were 105 patients with DILV and 35 patients with TA-TGA. The overall mortality
rate, including OHT, was 29%. Patients with DILV had a lower mortality rate than patients
with TA-TGA (23% vs. 49%, p  0.007). Multivariate analysis showed the presence of
arrhythmia and pacemaker requirement as independent risk factors for mortality, whereas
pulmonary atresia or stenosis and pulmonary artery banding were associated with decreased
mortality. Gender, era of birth, aortic arch anomaly, and systemic outflow obstruction were
not risk factors. The perioperative and overall mortality were similar between patients who
underwent the Damus-Kaye-Stansel procedure beyond the neonatal period and those had
subaortic resection.
CONCLUSIONS The mortality of patients with DILV or TA-TGA remains high. The outcomes of these
patients are influenced by restriction of pulmonary blood flow, arrhythmia, and pacemaker
requirement. Surgical palliation to relieve systemic outflow obstruction is not associated with
a poor outcome. (J Am Coll Cardiol 2004;43:113–9) © 2004 by the American College of
Cardiology Foundation
Double-inlet left ventricle (DILV) and tricuspid atresia
with transposed great arteries (TA-TGA) are two forms of
a single left ventricle (LV) at risk of developing systemic
outflow obstruction and poor outcomes (1–11). Patients
with these types of congenital heart disease frequently have
an associated aortic arch anomaly and may develop pulmo-
nary vascular disease due to excessive pulmonary blood flow
(5,6). Survival without surgical palliation in this group of
patients is poor. Franklin et al. (12) reported a 10-year
predicted survival of 11% for patients with systemic outflow
obstruction in addition to unobstructed pulmonary blood
flow and 79% for patients with pulmonary stenosis and no
systemic outflow obstruction.
Systemic outflow obstruction in patients with DILV or
TA-TGA can be relieved by the Damus-Kaye-Stansel
(DKS) procedure or by resection of the bulboventricular
foramen (BVF) and/or the subaortic muscle bundles. It has
been speculated that the DKS procedure may provide better
outcomes than BVF/subaortic resection, because BVF/
subaortic resection carries an increased risk of complete
heart block (13,14). In addition, many believe that pulmo-
nary artery banding (PAB) can reduce LV end-diastolic
volume, change LV geometry, and thereby lead to acceler-
ation of systemic outflow obstruction (3,6,8,9,15–17). Al-
though the surgical mortalities of these patients have de-
creased in the current era, it remains unclear whether the
different surgical approaches and anatomic variables impact
the long-term outcomes (18,19).
The goals of this study were to examine our single-
institution experience with surgical palliation of these types
of single LV heart defect over 20 years and to determine the
effects of anatomic characteristics and surgical management
on the long-term outcomes of these children.
METHODS
Patient selection. From 1983 through 2002, there were
164 consecutive pediatric patients (18 years old) with
DILV or TA-TGA who were referred for surgical palliation
at our institution. We excluded patients with a Holmes
heart (DILV with normally related great arteries) or het-
erotaxy syndrome, as well as patients lost to follow-up (n 
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24). A total of 140 patients entered into the study, including
105 patients with DILV and 35 with TA-TGA.
Systemic outflow obstruction. Systemic outflow obstruc-
tion was defined as obstruction at the BVF or subaortic area,
as assessed by echocardiography and cardiac catheterization.
Continuous-wave Doppler imaging was used to interrogate
the flow velocity at the BVF and subaortic region to
calculate the peak instantaneous gradient. During cardiac
catheterization, catheter pullback or a simultaneous mea-
surement technique was used to assess the pressure gradient
between the LV and ascending aorta. For the purpose of
this study, we defined systemic outflow obstruction as a
resting peak instantaneous gradient 20 mm Hg by echo-
cardiography or a resting peak-to-peak gradient5 mm Hg
by cardiac catheterization. Systemic outflow obstruction was
considered clinically significant if the patient had findings of
LV hypertrophy. In our institution, surgical procedures to
relieve systemic outflow obstruction include the DKS pro-
cedure and resection of the BVF and/or subaortic muscle
bundles. Details of the DKS technique have been reported
by our group (20,21) and by others (22).
Clinical outcomes. Clinical outcomes were examined by
reviewing the medical records and most recent outpatient
follow-up at our institution and by contacting the referring
cardiologists. In this study, we defined a subject as having
tachyarrhythmia if the subject was treated for recurrent
tachyarrhythmia beyond the immediate postoperative pe-
riod for any surgical procedure. We used “failure of pallia-
tion” as the definition for mortality. This definition included
patients who died during the study period and patients who
underwent orthotopic heart transplantation (OHT) who
might be alive with a transplanted heart at the time of
follow-up.
Statistical analysis. All data are expressed as the mean
value  SD, unless otherwise stated. The Student t test was
used for comparing continuous variables between groups.
Categorical data were compared using the chi-square test. A
p value 0.05 was considered statistically significant. All
statistical analyses were performed using SPSS version 8.0
for Windows (SPSS Inc., Chicago, Illinois).
Multiple regression analysis was conducted to evaluate
the predictors for mortality or the need for OHT. Kaplan-
Meier survival analyses were conducted for all study subjects
and for DILV and TA-TGA subgroups separately to
compare the survival of these patients up to 25 years of age.
RESULTS
Patient characteristics. There were 140 patients in the
study, with male predominance: 103 males (74%) and 37
females (26%). Of the patients, 78 (56%) were born before
1990 and 62 patients (44%) were born after 1990. There
were 105 patients (75%) with DILV and 35 patients (25%)
with TA-TGA. The mean age of the patients at the last
follow-up was 11.8  8.0 years (median 11.9 years, range
0.02 to 33 years). The median follow-up period was 7.7
years (range 0.01 to 28 years). The mean follow-up periods
for patients with DILV and TA-TGA were 9.2  5.8 years
and 6.3  6.0 years, respectively (p  0.01).
Mortality. The overall actuarial mortality rate, including
patients who underwent OHT, was 29% (n 41, 8 patients
underwent OHT) for the entire cohort of 140 patients.
There were 19 perioperative deaths (14% perioperative
mortality rate) and 22 late deaths (Table 1). The majority of
the perioperative deaths occurred in neonates who under-
went the DKS procedure (n  9). Five patients died of
postoperative arrhythmia. The majority of the late deaths
were related to dilated cardiomyopathy or tachyarrhythmia.
Figure 1 shows the Kaplan-Meier survival curve for all
patients. The predicted survival rates for all study patients at
5, 10, 15, and 25 years were 83%, 80%, 75%, and 52%,
respectively.
Patients with DILV had better overall survival than
patients with TA-TGA (Fig. 2). The predicted survival
rates at 5, 15, and 25 years were 89%, 80%, and 63%,
respectively, for patients with DILV, and 68%, 63%, and
26%, respectively, for patients with TA-TGA. The differ-
ences in the survival rates were most evident in the first five
years of life and during the late teen years. Table 2 compares
the demographic, anatomic, and surgical variables between
Abbreviations and Acronyms
BVF  bulboventricular foramen
DILV  double-inlet left ventricle
DKS  Damus-Kaye-Stansel
LV  left ventricle/ventricular
OHT  orthotopic heart transplantation
OR  odds ratio
PAB  pulmonary artery band/banding
Qp/Qs  pulmonary blood flow to systemic blood
flow ratio
TA-TGA  tricuspid atresia with transposed great
arteries
Table 1. Causes of 41 Deaths, Including Heart Transplantation,
in the Study Population
n
% of All
Mortality
Perioperative mortality 19 46
Neonatal DKS 9 22
Arrhythmia or sudden death after
Fontan operation or Fontan conversion 5 12
BVF resection or DKS procedure 2 5
Pacemaker placement 1 2
BVF resection 1 2
Clotted mechanical valve 1 2
Late mortality 22 54
Tachyarrhythmia 5 12
Sudden death 2 5
Dilated cardiomyopathy 12* 29
HIV infection 1 2
Sepsis 2 5
*Including eight patients who underwent orthotopic heart transplantation.
BVF  bulboventricular foramen; DKS  Damus-Kaye-Stansel; HIV  human
immunodeficiency virus.
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DILV and TA-TGA patients. The overall mortality rate for
patients with TA-TGA (49%) was significantly higher than
that for patients with DILV (24%) (p  0.007). A higher
proportion of patients with TA-TGA (n  10; 29%)
required neonatal DKS, compared with nine patients (9%)
with DILV-TGA (p  0.007). Eight of the 12 patients
(67%) with TA-TGA who were 15 years old developed
tachyarrhythmia between age 15 and 20 years, compared
with 39% of patients with DILV (p  0.16).
Systemic outflow obstruction and surgical management.
Ninety-two patients (66%) developed systemic outflow ob-
struction and underwent the DKS procedure (n  51)
and/or BVF/subaortic resection (n  44) to relieve the
obstruction. There were 30 deaths (32% mortality rate) in
this group of patients, including three perioperative deaths.
This mortality rate was not statistically different from the
24% overall mortality rate in patients who did not require
surgical relief of obstruction (p  0.5). The perioperative
mortality for BVF/subaortic resection was similar to the
perioperative mortality for the DKS procedure performed
beyond the neonatal period (2% vs. 3%, p  0.6). In
addition, patients who had the DKS procedure had a
cumulative mortality rate similar to that of patients who had
BVF/subaortic resection (33% vs. 32%, p  0.95). Among
the 44 patients who underwent BVF/subaortic resection, 15
patients (34%) developed complete heart block requiring
pacemaker placement.
Pulmonary or subpulmonary stenosis and PAB. By uni-
variate analysis, the mortality rate of patients without
pulmonary or subpulmonary stenosis was not statistically
different from that of patients with pulmonary or subpul-
monary stenosis (36% vs. 19%, p  0.055) (Table 3), nor
was there a statistically significant difference in the mortality
rates between patients who underwent PAB and those who
did not (23% vs. 39%, p  0.078) (Table 3). However, by
multivariate analysis, the odds ratio (OR) for mortality was
Figure 1. Kaplan-Meier survival curve for all-cause mortality in the entire
cohort (n  140) up to 25 years of age.
Figure 2. Kaplan-Meier survival curve for all-cause mortality of patients
with double-inlet left ventricle up to 25 years of age (n  105; solid line)
and patients with tricuspid atresia with transposed great arteries (n  35;
broken line).
Table 2. Characteristics of Patients With a DILV and Patients
With TA-TGA
DILV
Group
(n  105)
TA-TGA
Group
(n  35)
p
Value
Gender (M/F) 77/28 26/9 0.91
Mortality 24 (23) 17 (49) 0.007
Tachyarrhythmia 21 (20) 13 (37) 0.069
Complete heart block 21 (20) 3 (9) 0.20
Pacemaker placement 31 (30) 7 (20) 0.38
Arch anomaly 30 (29) 11 (31) 0.91
Pulmonary atresia/stenosis 44 (42) 11 (31) 0.37
Pulmonary artery banding 72 (69) 17 (49) 0.054
DKS procedure 38 (36) 13 (37) 0.92
BVF/subaortic resection 36 (34) 8 (23) 0.29
Data are presented as the number (%) of patients.
DILV  double-inlet left ventricle; TA-TGA  tricuspid atresia with transposed
great arteries; other abbreviations as in Table 1.
Table 3. Univariate Analysis of Baseline and Surgical Variables
Associated With Mortality
Relative
Risk*
p
Value
Baseline variables
TA-TGA vs. DILV 2.13 0.007
Tachyarrhythmia (yes vs. no) 2.69 0.0002
PA/PS (present vs. absent) 0.53 0.055
Coarctation of aorta (present vs. absent) 1.55 0.15
Gender (male vs. female) 0.77 0.48
L-loop vs. D-loop ventricle 0.81 0.54
Surgical variables
Neonatal DKS procedure 2.79 0.0004
Pacemaker placement 2.56 0.0004
Pulmonary artery banding 0.60 0.078
BVF/subaortic resection 1.13 0.81
DKS procedure beyond neonatal period 1.24 0.55
*Relative risks for mortality were calculated using the underlined groups as the
reference (relative risk  1.0).
PA/PS  pulmonary atresia/pulmonary stenosis; other abbreviations as in Tables
1 and 2.
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significantly lower in patients who had pulmonary or sub-
pulmonary stenosis or PAB (OR 0.11 and 0.15, respec-
tively) than in those who did not have pulmonary or
subpulmonary stenosis or PAB (Table 4).
In the comparison of pre-Fontan hemodynamic data,
patients who had undergone PAB had higher saturation
than patients who had undergone aortopulmonary shunt
procedures (85  6% vs. 79  10%, p  0.002). However,
there was no statistically significant difference between the
two groups in pulmonary artery pressure (14 4 mm Hg vs.
15  6 mm Hg, p  0.44), transpulmonary gradient (6 
3 mm Hg vs. 6  3 mm Hg, p  0.85), and LV
end-diastolic pressure (9  3 mm Hg vs. 8  3 mm Hg, p
 0.77).
Arrhythmia and pacemaker placement. Of the patients,
34 (24%) developed recurrent late tachyarrhythmia during
the study period. The tachyarrhythmia included atrial flut-
ter/atrial fibrillation (n  26), supraventricular tachycardia
(n  3), and ventricular tachycardia (n  5); 38 patients
(27%) underwent pacemaker placement. Complete heart
block was the most common indication for a pacemaker,
accounting for two-thirds of all pacemaker placements
(Table 5). By univariate analysis, both tachyarrhythmia and
pacemaker requirement were strongly associated with in-
creased mortality (Table 3). The mortality rate was 56% for
patients who developed tachyarrhythmia, compared with
21% for those who did not (p  0.0002), and 53% for
patients who required pacemaker placement compared with
21% for those who did not (p  0.0004). By multivariate
analysis, both pacemaker requirement and the presence of
tachyarrhythmia were significant independent risk factors
for mortality (OR 4.5 and 4.5, respectively) (Table 4).
Other variables. Variables such as gender, era of birth
(before vs. after 1990), atrioventricular valve atresia, coarc-
tation or arch anomaly, and systemic outflow obstruction
were not independent predictors of mortality by multiple
regression analysis (Table 4).
Fontan palliation. Of the 140 study patients, 95 (68%)
underwent the Fontan operation; 11 patients were awaiting
the Fontan operation. Thus, 76% of the study patients were
considered as candidates for the Fontan operation. Of the
patients, 34 (24%) in our series were not candidates for the
Fontan operation because of high pulmonary vascular resis-
tance (n 14), poor ventricular function (n 5), and death
before the Fontan operation (n  15). Of the 95 patients,
42 (44%) who had undergone the Fontan operation were
staged with a Glenn shunt before the operation. The overall
mortality rate for patients who completed the Fontan
sequence was 22%, including five perioperative deaths (5%
mortality) and 16 late deaths. Nonsurvivors had higher
pulmonary artery pressure on the pre-Fontan catheteriza-
tion than survivors (17  7 mm Hg vs. 13  3 mm Hg, p
 0.03) (Table 6). The ages at the Fontan operation for
survivors and nonsurvivors were similar (5.0  2.9 years
[median 4.3] vs. 5.6  3.6 years [median 4.8], p  0.53).
Among 42 patients who were staged with a Glenn shunt
before the Fontan operation, there were 5 deaths (12%
mortality rate), including 2 perioperative deaths and three
late deaths. In comparison, there were 16 deaths (30%
mortality rate), including 3 perioperative and 13 late deaths,
among 53 patients who were not staged before the Fontan
operation (p  0.06). For the nonsurvivors, the mean age at
the time of the Fontan operation was not statistically
different between patients staged with a Glenn shunt and
those nonstaged (3.4  1.1 years [median 3.8] vs. 5.5  3.1
years [median 4.8], p  0.16). However, patients who were
not staged with a Glenn shunt were older at the time of
death. The mean age at the time of death for patients with
Table 4. Multivariate Analysis for Mortality Risk Factors
Independent Variables
Odds
Ratio* 95% Cl
p
Value
Demographic variables
Male gender (female) 0.59 0.21–1.58 0.29
Born after 1990 (before 1990) 1.11 0.37–3.27 0.86
Anatomic variables
TA-TGA (DILV) 1.54 0.39–6.09 0.53
Presence of PA/PS (no PA/PS) 0.11 0.02–0.73 0.02
Coarctation of aorta (no coarctation) 3.02 0.80–11.4 0.10
AV valve atresia (no AV valve atresia) 2.05 0.56–7.46 0.28
Surgical variables
BVF/subaortic resection 1.61 0.47–5.49 0.45
Pulmonary artery banding 0.15 0.03–0.61 0.01
DKS procedure 0.61 0.15–2.51 0.49
Pacemaker placement 4.53 1.56–13.14 0.006
Tachyarrhythmia 4.52 1.40–14.64 0.01
*Odds ratios for mortality were calculated using the groups in parenthesis as the
reference (odds ratio  1.0).
AV  atrioventricular; CI  confidence interval; other abbreviations as in Tables
1 and 2.
Table 5. Indications for Pacemaker Placement
Reason for Pacemaker
DILV Group
(n  31 [30%])
TA-TGA
Group
(n  7 [20%])
Sick sinus syndrome 10 4
Complete heart block secondary to
BVF resection 13 2
Spontaneous 3 0
Cardiac catheterization 3 1
DKS procedure 1 0
Abbreviations as in Tables 1 and 2.
Table 6. Comparisons of Pre-Fontan Hemodynamic Data by
Cardiac Catheterization Between Survivors and Nonsurvivors
Nonsurvivors
(n  15)
Survivors
(n  63)
p
Value
Pulmonary artery pressure
(mm Hg)
17  7 13  4 0.03
Transpulmonary gradient
(mm Hg)
7  2 6  3 0.17
LVEDP (mm Hg) 8  3 8  3 0.84
BVF gradient (mm Hg) 14  22 9  14 0.28
Pulse oximetry (%) 85  6 83  7 0.37
Qp/Qs ratio 1.8  1.0 1.3  0.7 0.15
Data are presented as the mean value  SD.
BVF  bulboventricular foramen; LVEDP  left ventricular end-diastolic
pressure; Qp/Qs  pulmonary blood flow to systemic blood flow ratio.
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the Fontan operation without staging was 15.0  7.5 years
(median 16.9), compared with 8.1  4.9 years (median 8.4,
p  0.07) for the patients who were staged with a Glenn
shunt. The pre-Fontan hemodynamics, with the exception
of the pulmonary blood flow to systemic blood flow (Qp/
Qs) ratio, were not significantly different between the
patients staged with a Glenn shunt and those without
staging. Patients not staged with a Glenn shunt had a
higher Qp/Qs ratio (1.61 0.81 vs. 1.03 0.41, p 0.01).
DISCUSSION
Although the clinical outcomes of patients with DILV and
TA-TGA have improved significantly from the studies
published in the late 1980s (1,5), the overall mortality rate
in these patients remains high, despite advancement in
medical and surgical management. The cumulative actuarial
mortality was 29% (including eight patients who underwent
OHT) for our cohort of patients. Because our institution is
one of the major referring centers for OHT, this high
cumulative mortality may partly result from a selection bias.
Nonetheless, this study supports that even with improved
surgical palliation, the longevity of a single-ventricle heart
remains guarded, with only 52% of the patients having a
single LV expected to survive beyond 25 years of age.
Several studies have shown that systemic outflow obstruc-
tion results in ventricular hypertrophy and ischemia, leading
to a poor outcome (1–11). The overall survival rate of 68%
among our patients with systemic outflow obstruction was
apparently higher than that reported by Franklin et al. (12)
in 1990, where only 15% of patients with DILV and TGA
with systemic outflow obstruction survived at 8.5 years of
follow-up (5). Additionally, systemic outflow obstruction in
the present study was not a significant risk factor for
mortality. Although 66% of our patients required surgical
intervention for systemic outflow obstruction, the mortality
rate for this group of patients was not statistically different
from that of patients who did not develop obstruction. We
believe that this discrepancy is due to the early recognition
and treatment of hemodynamically significant obstruction
in our patients. Indeed, very few patients in our study had
hemodynamically significant obstruction for a prolonged
period. In fact, the survivors and nonsurvivors had a similar
systemic outflow gradient on pre-Fontan catheterization.
We had previously proposed that neonates with
moderate-size BVF and coarctation could be effectively
managed with PAB and repair of the coarctation in the
neonatal period, followed by a combined Glenn shunt and
DKS at four to six months of age (23). In that study,
short-term systemic outflow obstruction did not negatively
impact the surgical outcomes of these patients. The present
study suggests that short-term and hemodynamically insig-
nificant obstruction (i.e., presence of a gradient without
significant ventricular hypertrophy) does not have a signif-
icant impact on long-term outcome either. O’Leary et al. (7)
showed that ventricular hypertrophy and LV end-diastolic
pressure improved after relief of obstruction. This may
partly explain why short-term obstruction did not impact
the long-term outcomes of these patients. However, sys-
temic outflow obstruction remains a potential threat to the
long-term outcomes of patients with DILV or TA-TGA. It
is well recognized that many patients who did not have
obstruction at presentation develop obstruction over time
and after volume-reducing surgeries, such as PAB or the
Fontan operation (3,6,8,9,15–17). We have similarly seen a
few patients who had “large and unobstructive” BVF as
infants who eventually developed cardiomyopathy and re-
quired OHT secondary to significant obstruction years after
the Fontan operation. This emphasizes the importance of
vigilant follow-up for the development of systemic outflow
obstruction in these patients.
Although PAB reduces ventricular volume load and can
potentially facilitate development of systemic obstruction
(3,5,6,15–17,24), PAB itself does not appear to be a risk
factor for mortality. In fact, our study showed that protec-
tion of the pulmonary vascular bed, either by native pulmo-
nary or subpulmonary stenosis or a surgically placed PAB, is
beneficial to the survival of patients with these congenital
heart defects. Although PAB could potentially cause pul-
monary artery distortion or pulmonary insufficiency and
thus make a future Fontan or DKS procedure more difficult,
we and others (17,23,25–27) have found that a well-
positioned short-term PAB is generally well tolerated in
these patients and does not compromise subsequent surgical
palliation or long-term survival.
Our data further support that pulmonary or subpulmo-
nary stenosis is advantageous for an improved outcome (12).
Some may argue that patients with pulmonary or subpul-
monary stenosis have a better outcome because they tend to
have a large BVF and are less likely to develop systemic
outflow obstruction. However, our data suggest that the
survival advantage for this group of patients is not due to the
lack of obstruction. When we adjusted for systemic outflow
obstruction as a variable, those patients with pulmonary or
subpulmonary stenosis still had better survival. The protec-
tive effect of pulmonary and subpulmonary stenosis is most
likely secondary to protection of the pulmonary vascular
bed, which makes the patient a better candidate for Fontan
palliation. This is further supported by the fact that among
patients who had undergone the Fontan operation, nonsur-
vivors had higher pulmonary artery pressure on the pre-
Fontan catheterization than survivors.
Of our patients, 76% were considered as Fontan candi-
dates; 68% of these patients had already undergone the
Fontan operation. This is higher than the rate reported by
Franklin et al. (12) in 1991, where only 57% of the patients
were suitable candidates for the Fontan operation. Of the
patients who were not candidates for the Fontan operation,
a major determinant of whether the patient was a Fontan
candidate was pulmonary vascular resistance. A comparison
of patients who were evaluated for Fontan palliation showed
that patients who had undergone PAB had higher satura-
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tion than patients who had undergone an aortopulmonary
shunt procedure; however, they had similar LV end-
diastolic pressure. These data suggest that PAB is an
effective procedure to control pulmonary blood flow and
provide adequate saturation without a negative impact on
ventricular compliance.
Of our patients who had the Fontan operation, 44% were
staged with a Glenn shunt. We found that patients who
were not staged with a Glenn shunt tended to have worse
outcomes (mortality 30% vs. 12% for patients who were
staged, p  0.06). However, patients who were not staged
with a Glenn shunt were older at the time of death;
therefore, the difference in mortality between the two
groups of patients may be due to difference in age rather
than staging. Alternatively, patients who were not staged
with a Glenn shunt had a higher Qp/Qs ratio than those
staged, and their ventricles were under higher volume load
and thus at greater risk of poor ventricular compliance.
We also found that a pacemaker requirement and the
presence of tachyarrhythmia were significant risk factors for
mortality. The perioperative mortality rates for BVF/
subaortic resection and the DKS procedure performed
beyond the neonatal period were similar. However, 15
(34%) of 44 subaortic resections were complicated by
complete heart block. The reason for pacemaker require-
ment as a significant risk factor for mortality was largely due
to late deaths, not perioperative deaths. We speculate that it
might be some other variables associated with pacemaker
and pacemaker requirement that accounted for the late
deaths of patients, and the pacemaker itself might not have
been the cause of deaths. Because the majority of patients
who had pacemaker placement had a DDD pacemaker, it is
unlikely that the poor outcome was due to a lack of
atrioventricular synchrony. Whether or not pacemaker-
induced cardiomyopathy due to asynchrony of the ventric-
ular contraction occurs in patients with a single ventricle
remains to be examined.
Atrial tachycardia is the most common type of arrhyth-
mia seen in children after a Fontan operation and has been
reported to range from 17% to 50% in follow-up periods of
up to 15 years (28–33) and has been shown to be strongly
associated with persistent hemodynamic abnormalities (31).
Twenty-four percent of our study patients developed recur-
rent late tachyarrhythmia, the majority being atrial tachy-
cardia, with 56% cumulative mortality. In this study, by
both univariate and multivariate analyses, recurrent late
tachyarrhythmia was a strong predictor of a poor outcome.
Although Ghai et al. (33) and Gewillig et al. (28) showed
no statistically significant association between late arrhyth-
mia and mortality in adult patients with the Fontan oper-
ation, our study is in agreement with the study by Humes et
al. (34), which reported a significant number of late deaths
(26%) attributable to arrhythmia. Whether or not this
discrepancy in the findings is due to a different study
population (adults vs. children, types of single ventricles
being studies) is unclear.
Although the subgroup of patients with TA-TGA was
younger and had a shorter follow-up time than patients with
DILV, our study showed a significantly higher mortality
rate in the former group (49% vs. 23%). This difference in
mortality was most evident in the first five years of life and
during the late teen years. The early mortality in TA-TGA
patients was largely due to perioperative deaths associated
with the neonatal DKS procedure. The late mortality in
these patients may be associated with a higher rate of
tachyarrhythmia during the late teens for the TA-TGA
subgroup. In this study, we did not compare the outcomes
between patients with TA-TGA and patients with tricuspid
atresia and normally related great arteries. More studies are
needed to investigate the impact of the relation of great
arteries on surgical treatment and long-term outcomes of
patients with tricuspid atresia.
Conclusions. Although surgical mortality has been signif-
icantly reduced, the long-term outcomes of patients with
DILV and TA-TGA, albeit improved compared with the
last large series study, remain poor. Patients with DILV
have better overall outcomes than those with TA-TGA.
Late arrhythmia and pacemaker requirement are indepen-
dent risk factors for mortality. Systemic outflow obstruction,
as long as it is recognized and relieved early, has no
significant impact on long-term survival. Protection of the
pulmonary vascular bed by either naturally occurring pul-
monary or subpulmonary stenosis or by PAB, is associated
with better survival.
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